This randomized, placebo-controlled trial - a collaboration between two major academic medical centers (University of Kentucky and University of Alabama at Birmingham) - is designed to determine if the addition of a medication (Metformin) will improve the effectiveness of strength training in older adults. The overall goal is to establish a low cost, personalized approach to prevent frailty in older adults.
Welcome to REACT
REACT-Led Clinical Trials in Medical Rehabilitation
Pilot Studies Awardees
Clinical Lectures, Vignettes & Courses
News Updates See all news
Public input requested on important new directions for health-related behavioral and social sciences research (BSSR).Announcements · March 6, 2020
Are you a breast cancer survivor having difficulty walking? Do you have any lower-body pain that is restricting your mobility? If so, you may be interested in taking part in an exercise training intervention. UAB researchers are currently looking for overweight women with a history of breast cancer to participate in a novel exercise training study.
The study uses a theory-driven eHealth platform and innovative PA program referred to as movement-to-music (M2M) to deliver a customized, home-based PA intervention for adults with physical disability. Participants will be recruited through a large physical medicine and rehabilitation network of clinics specializing in treating patients with physical disability.
The objective of this pilot study is to investigate the effects of a 6-week structured exercise program on memory function and associated brain network connectivity in persons with epilepsy (PWE).
The purpose of this project is to conduct a randomized, controlled trial (RCT) to determine if choice of antihypertensive medication influences changes in functional status and other cardiovascular risk factors among older persons with hypertension.
The purpose of this study is to evaluate the impact of a 16-week resistance and interval intensity training program for older adults with HIV on mitochondrial function and frailty risk. Participants will be HIV+ men and women between the ages of 55 and 85.